Table 1.
Baseline characteristics of patients with AF and factors associated with death or stroke
| Patient characteristics | Number of patients (%) |
|---|---|
| Age, mean ± SD, years | 63.41±12.20 |
| Sex | |
| Male | 118 (54.38) |
| Female | 99 (45.62) |
| BMI, mean ± SD, kg/m2 | 24.32±3.59 |
| Education | |
| Junior school and below | 173 (79.72) |
| High school and above | 44 (20.27) |
| Income (10,000 RMB/year) | |
| <2.5 | 110 (50.69) |
| ≥2.5 | 107 (49.31) |
| AF type | |
| Paroxysmal | 68 (31.34) |
| Persistent | 149 (68.66) |
| Smoking status | |
| Former/current | 73 (33.64) |
| Never | 144 (66.36) |
| Drinking status | |
| Former/current | 76 (35.02) |
| Never | 141 (64.98) |
| Warfarin treatment | |
| Yes | 65 (29.96) |
| No | 152 (70.04) |
| Statin treatment | |
| Yes | 97 (44.70) |
| No | 120 (55.30) |
| History of combined diseases | |
| Hypertension | 109 (50.23) |
| Diabetes | 33 (15.21) |
| Coronary heart disease | 83 (38.25) |
| Cardiomyopathy | 22 (10.14) |
| Heart failure | 78 (35.94) |
| TIA | 9 (4.15) |
| Vascular diseases | 14 (6.45) |
| Previous stroke | 18 (8.29) |
| IL-6, median (range), pg/mL | 28.3 (0.3–216.2) |
| ≤55.2 | 184 (84.79) |
| >55.2 | 33 (15.21) |
| CHA2DS2-VASc score | |
| <2 | 68 (32.72) |
| ≥2 | 146 (67.28) |
| Follow-up time, mean (IQR), month | 27 (23–30) |
| stroke | 15 (6.91) |
| All-cause mortality | 24 (11.06) |
AF - atrial fibrillation; BMI - body mass index; IL - interleukin; SD - standard deviation; TIA - transient ischemic attack